-
1
3
,7,7-Trimethyl-6-methylamino-5,6,7,8-tetrahydroindolizinone (3d). IR spectrum, ν, cm : 3350
1
(
(
NH), 1675 (C=O). H NMR spectrum, δ, ppm, (J, Hz): 1.18, 1.29 (both 2H, both s, 7-(CH ) , 7-(CH ) ); 2.28
3
a
3 b
3H, s, 3-CH ); 2.51 (3H, s, 6-NHCH ); 2.93 (1H, dd, J = 6.8, J65b = 3.8, H-6); 3.80 (1H, dd, J5a5b = 13.1,
3
3
65a
J5a6 = 6.8, H -5); 4.12 (1H, dd, J
= 13.1, J = 3.8, H -5); 6.04 (1H, d, J = 3.7, H-2); 6.95 (1H, d, J = 3.7,
a
5b5a
5b6
b
21
12
+
+
+
H-1). Mass spectrum, m/z (I , %): 206 [M] (42), 121 [M - C(CH ) CHNHCH ] (33), 98 [M - C H NO] (100).
rel
3 2
3
6
5
Found, %: C 69.77; H 8.89; N 13.35. C H N O. Calculated, %: C 69.87; H 8.79; N 13.58.
1
2
18
2
-
1
6
-Ethylamino-3,7,7-trimethyl-5,6,7,8-tetrahydroindolizinone (3e). IR spectrum, ν, cm : 3340 (NH),
1
1
650 (C=O). H NMR spectrum, δ, ppm, (J, Hz): 1.12 (3H, t, J = 7.1, 6-NHCH
s, 7-(CH , 7-(CH ); 2.27 (3H, s, 3-CH ); 2.65, 2.82 (both 1H, both dq, J = 7.1, J = 10.4, 6-NHCH
.03 (1H, dd, J65a = 7.3, J65b = 4.5, H-6); 3.74 (1H, dd, J5a6 = 7.3, J5a5b = 12.5, H -5); 4.11 (1H, dd, J5b6 = 4.5,
5b5a = 12.5, H -5); 6.05 (1H, d, J21 = 3.9, H-2); 6.95 (1H, d, J12 = 3.9, H-1). Mass spectrum, m/z (Irel, %): 220
2
CH
3
); 1.19, 1.29 (both 3H, both
3
)
a
3
)
b
3
a
H
b
CH );
3
3
J
[
a
b
+
+
+
M] (11), 177 [M - CH(CH
Calculated, %: C 70.87; H 9.15; N 12.72.
-Methylamino-5,6,7,8-tetrahydrospiro[cyclopentane-1,7'-indolizinone] (3f). IR spectrum, ν, cm :
3 2 6 5 20 2
) ] (26), [M - C H NO] (100). Found, %: C 70.80; H 9.25; N 12.79. C13H N O.
-
1
6
1
3
2 4
350 (NH), 1660 C=O). H NMR spectrum, δ, ppm, (J, Hz): 1.59 (1H, m, from 7'-(CH ) ); 1.72 (4H, m, from
7
'-(CH ); 1.94 (2H, m, from 7'-(CH ); 2.33 (1H, m, from 7'-(CH ); 2.44 (3H, s, 6-NHCH
2
)
4
2
)
4
2
)
4
3
); 2.95 (1H, t,
J = 3.4, H-6); 4.21 (2H, d, J = 3.4, 5-CH
2
); 6.26 (1H, dd, J = 2.2, J21 = 4.0, H-2); 6.78 (1H, t, J = 2.2, H-3); 6.96
+
+
(
[
1H, dd, J = 2.2, J12 = 4.0, H-1). Mass spectrum, m/z (Irel, %): 218 [M] (36), 162 [M - C
M - C H ] (16), 124 [M - C H NO] (100). Found, %: C 69.88; H 8.50; N 8.50. C13H N O. Calculated, %:
5 9 5 3 18 2
4
H
8
] (20), 149
+
+
C 71.52; H 8.31; N 12.83.
-Ethylamino-5,6,7,8-tetrahydrospiro[cyclopentane-1,7'-indolizinone] (3g). IR spectrum, ν, cm :
-
1
6
1
3
360 (NH), 1660 (C=O). H NMR spectrum, δ, ppm, (J, Hz): 1.06 (3H, t, J = 7.2, 6-NHCH
from 7'-(CH ); 1.89, 1.98, 2.29 (all 1H, all m, from 7'-(CH ); 2.58, 2.78 (both 1H, both dq, J = 7.2, J = 11.3,
-NHCH CH ); 3.16 (1H, t, J = 4.1, H-6); 4.12, 4.20 (both 1H, both dd, J = 4.1, J = 12.9, H -5, H -5); 6.26
1H, dd, J = 2.2, J21 = 4.1, H-2); 6.78 (1H, t, J = 2.2, H-3); 6.96 (1H, dd, J = 2.2, J12 = 4.1, H-1). Mass spectrum,
2 3
CH ); 1.70 (5H, m,
2
)
4
2 4
)
6
(
a
H
b
3
a
b
+
+
5 3 20 2
m/z (Irel, %): 232 [M] (20), 138 [M - C H NO] (100). Found, %: C 72.39; H 8.70; N 11.89. C14H N O.
Calculated, %: C 72.37; H 8.67; N 12.05.
-
1
2
,2-Dimethyl-3-methylamino-α-tetralone (6a). IR spectrum, ν, cm : 3370 (NH), 1680 (C=O).
H NMR spectrum, δ, ppm, (J, Hz): 1.17, 1.28 (both 3H, both s, 2-(CH , 2-(CH ); 2.47 (3H, s, 3-NHCH );
.85 (1H, dd, J34b = 3.7, J34a = 7.2, H-3); 2.90 (1H, dd, J4a3 = 7.2, J4a4b = 16.8, H -4); 3.24 (1H, dd, J4b3 = 3.7,
4b4a = 16.8, H -4); 7.23 (1H, d, J = 7.8, H-6); 7.30 (1H, t, J = 7.8, H-8); 7.46 (1H, dt, J = 7.8, J79 = 1.2, H-7);
1
3
)
a
3
)
b
3
2
a
J
8
1
b
+
+
3 2
.02 (1H, dd, J = 7.8, J97 = 1.2, H-9). Mass spectrum, m/z (Irel, %): 203 [M] (55), 160 ([M - CH(CH ) ] (100),
18 [M - C(CH
+
3
)
2
CHNHCH
3
] (33). Found, %: C 76.64; H 8.53; N 6.83. C13
H17NO. Calculated, %: C 76.81;
H 8.43; N 6.89.
-
1
1
3
-Ethylamino-2,2-dimethyl-α-tetralone (6b). IR spectrum, ν, cm : 3360 (NH), 1670 (C=O). H NMR
spectrum, δ, ppm, (J, Hz): 1.08 (3H, t, J = 7.1, 3-NHCH
2
CH
.59, 2.83 (both 1H, both dq, J = 7.1, J = 11.4, 3-NHCH
.95 (1H, dd, J34b = 2.9, J34a = 7.9, H-3); 3.22 (1H, dd, J4b3 = 2.9, J4b4a = 15.5, H
.30 (1H, t, J = 7.6, H-7); 7.47 (1H, dt, J = 7.6, J68 = 1.5, H-6); 8.02 (1H, dd, J = 7.6, J86 = 1.5, H-8). C NMR
CH ); 19.0 (q, J = 123.1,
); 42.6 (t, J = 129.5, C(4)); 47.0 (s, C(2));
2.0 (d, J = 131.3, C(3)); 126.7 (dd, J = 163.2, J = 8.0, C(5)); 127.8 (dd, J = 161.0, J = 7.6, C(6)); 129.1 (dm,
3
); 1.16, 1.28 (both 3H, both s, 2-(CH
CH ); 2.90 (1H, dd, J4a3 = 7.9, J4a4b = 15.5, H
-4); 7.22 (1H, d, J = 7.6, H-5);
3
)
a
, 2-(CH
3
)
b
);
2
2
7
a
H
b
3
a
-4);
b
1
3
spectrum without proton decoupling, δ, ppm, (J, Hz): 15.4 (q, J = 125.2, 3-NHCH
2
3
2
3 a 3 b 2 3
-(CH ) ); 22.5 (q, J = 127.4, 2-(CH ) ); 31.6 (t, J = 127.8, 3-NHCH CH
6
J = 157.0, C(7)); 131.2 (m, C(4)); 133.3 (dd, J = 159.6, J = 8.8, C(8)); 140.3 (m, C(8a)); 202.4 (s, C(1)). Mass
+
+
spectrum, m/z (Irel, %): 217 [M] (100), 174 [M - CH
2
] (41). Found, %: C 77.45; H 8.42; N 6.52. C14
H19NO.
Calculated, %: C 77.38; H 8.75; N 6.44.
-
1
3
-Methylaminospiro[cyclohexane-1,2'-α-tetralone] (6d). IR spectrum, ν, cm : 3380 (NH), 1680
1
(
C=O). H NMR spectrum, δ, ppm, (J, Hz): 1.55 (7H, m, from 2'-(CH
2
)
5
); 1.75, 1.84, 2.17 (all 1H, all m, from
2
'-(CH ); 2.42 (3H, s, 3-NHCH ); 3.10 (1H, dd, J4a3 = 2.9, J4a4b = 17.3, H
2
)
5
3
a
-4); 3.18 (1H, t, J = 2.9, H-3); 3.25
1
305